Trial intelligence / Profile preview

Multi-Omics Research of Danhong Injection for Acute Ischemic Stroke

NCT02176395Phase 4Completed

Sponsor
China Academy of Chinese Medical Sciences
Start
Jun 2014
Primary completion
Mar 2019
Modality
Botanical drug
Countries
1
01

Overview

A Phase 4 trial of danhong injection in ischemic stroke, sponsored by China Academy of Chinese Medical Sciences. Started Jun 2014; status: completed.

02

Drugs

danhong injection
03

Conditions

ischemic stroke

Beyond the preview

Go deeper on NCT02176395.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02176395.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call